Psychological factors that influence decision making about prophylactic surgery

We reviewed the empirical literature on psychosocial factors influencing women’s decisions to undergo prophylactic surgery. A total of 34 studies were identified. The majority of studies found that women’s cancer-specific worries and risk perceptions exerted considerable influence in decision making about prophylactic surgery. Higher levels of cancerspecific anxiety were positively associated with interest in and intention to undergo surgery. In addition, greater perceived risk was also associated with greater interest and uptake of prophylactic surgery. Women also cited issues concerning body image and sexuality, familial responsibilities, and cultural norms as influencing the decision-making process. Several studies have begun to evaluate the impact of decision aids and counseling interventions, but additional studies are still needed to evaluate the long-term psychosocial, behavioral, and medical implications of these interventions. Decision counseling and preference clarification may be useful in facilitating the selection between different behavioral alternatives and in enhancing patient outcomes.

[1]  C. Spielberger State‐Trait Anxiety Inventory , 2010 .

[2]  Suzanne M. Miller,et al.  Enhanced Counseling for Women Undergoing BRCA1/2 Testing: Impact on Subsequent Decision Making About Risk Reduction Behaviors , 2005, Health education & behavior : the official publication of the Society for Public Health Education.

[3]  M. Brännström,et al.  Differences in aspects of personality and sexuality between perimenopausal women making different choices regarding prophylactic oophorectomy at elective hysterectomy , 2005, Acta obstetricia et gynecologica Scandinavica.

[4]  R. Myers,et al.  Decision counseling in cancer prevention and control. , 2005, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[5]  H. Valdimarsdottir,et al.  Decision making and decision support for hereditary breast-ovarian cancer susceptibility. , 2005, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[6]  Terry Connolly,et al.  Regret in cancer-related decisions. , 2005, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[7]  Y. Cheung,et al.  Acceptance of Prophylactic Surgery and Chemoprevention of Cancer in Singapore – , 2005 .

[8]  J. Husted,et al.  Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9]  G. Glendon,et al.  A multicenter study of supportive‐expressive group therapy for women with BRCA1/BRCA2 mutations , 2004, Cancer.

[10]  L. Hartmann,et al.  Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy. , 2004, American journal of obstetrics and gynecology.

[11]  W. Daal,et al.  Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  P. Butow,et al.  Short- and Long-Term Impact of Receiving Genetic Mutation Results in Women at Increased Risk for Hereditary Breast Cancer , 2004, Journal of Genetic Counseling.

[13]  Susan L Neuhausen,et al.  Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  A. Fiander,et al.  An exploratory qualitative study of women's perceptions of risk management options for familial ovarian cancer: implications for informed decision making. , 2004, Gynecologic oncology.

[15]  W. Foulkes,et al.  Prevention and genetic testing for breast cancer: variations in medical decisions. , 2004, Social science & medicine.

[16]  P. Hall,et al.  Preoperative psychological reactions and quality of life among women with an increased risk of breast cancer who are considering a prophylactic mastectomy. , 2004, European journal of cancer.

[17]  J. Oosterwijk,et al.  Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer , 2004, American journal of medical genetics. Part A.

[18]  P. Butow,et al.  Communication and information-giving in high-risk breast cancer consultations: influence on patient outcomes , 2004, British Journal of Cancer.

[19]  S. Narod,et al.  Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy , 2004, Psycho-oncology.

[20]  Suzanne M. Miller,et al.  Psychosocial correlates of intention to undergo prophylactic oophorectomy among women with a family history of ovarian cancer. , 2003, Preventive medicine.

[21]  C. Isaacs,et al.  Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  J. Klijn,et al.  Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  P. Butow,et al.  Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer. , 2003, Journal of women's health.

[24]  W. Otten,et al.  Genetic counselling and the intention to undergo prophylactic mastectomy: effects of a breast cancer risk assessment , 2003, British Journal of Cancer.

[25]  L. Fallowfield,et al.  A qualitative study looking at the psychosocial implications of bilateral prophylactic mastectomy. , 2003, Breast.

[26]  R. J. Cersosimo Tamoxifen for Prevention of Breast Cancer , 2003, The Annals of pharmacotherapy.

[27]  Mark E. Robson,et al.  Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation , 2002 .

[28]  P. Butow,et al.  Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study. , 2002, Gynecologic oncology.

[29]  Susan L Neuhausen,et al.  Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. , 2002, The New England journal of medicine.

[30]  J. Klijn,et al.  One Year Follow-Up of Women Opting for Presymptomatic Testing for BRCA1 and BRCA2: Emotional Impact of the Test Outcome and Decisions on Risk Management (Surveillance or Prophylactic Surgery) , 2002, Breast Cancer Research and Treatment.

[31]  R. L. Baldwin,et al.  Cancer incidence in a population of Jewish women at risk of ovarian cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  J Dowie,et al.  Development and preliminary evaluation of a clinical guidance programme for the decision about prophylactic oophorectomy in women undergoing a hysterectomy , 2002, Quality & safety in health care.

[33]  Suzanne M. Miller,et al.  The Influence of Attentional Style and Risk Perceptions on Intentions to Undergo Prophylactic Oophorectomy Among First-Degree Relatives , 2002 .

[34]  A. Cull,et al.  Deciding about prophylactic oophorectomy: what is important to women at increased risk of ovarian cancer? , 2001, Preventive medicine.

[35]  N. Lindberg,et al.  Anxiety and compliance among women at high risk for breast cancer , 2001, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[36]  I. Jacobs,et al.  Surveillance or surgery? A description of the factors that influence high risk premenopausal women's decisions about prophylactic oophorectomy , 2001, Journal of medical genetics.

[37]  W. Foulkes,et al.  Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another , 2001, Cancer.

[38]  J. Klijn,et al.  Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. , 2001, The New England journal of medicine.

[39]  A. Cull,et al.  Prophylactic oophorectomy versus screening: psychosocial outcomes in women at increased risk of ovarian cancer , 2001, Psycho-oncology.

[40]  S. Mahon Factors affecting genetic testing and decisions about prophylactic surgery. , 2001, Clinical journal of oncology nursing.

[41]  E. Warner,et al.  Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[42]  M. Daly,et al.  Anxiety/uncertainty reduction as a motivation for interest in prophylactic oophorectomy in women with a family history of ovarian cancer. , 2001, Journal of women's health & gender-based medicine.

[43]  J. Klijn,et al.  Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  E. Swisher,et al.  Prophylactic oophorectomy and ovarian cancer surveillance. Patient perceptions and satisfaction. , 2001, The Journal of reproductive medicine.

[45]  W. Foulkes,et al.  Variation in prophylactic surgery decisions , 2000, The Lancet.

[46]  M. Robson,et al.  Screening for ovarian cancer: what we know, what we need to know. , 2000, Oncology.

[47]  M. Watson,et al.  Understanding the experience of prophylactic bilateral mastectomy: a qualitative study of ten women , 2000, Psycho-oncology.

[48]  L. Andrews,et al.  Psychological impact of prophylactic oophorectomy in women at increased risk for ovarian cancer , 2000, Psycho-oncology.

[49]  N. Hallowell A qualitative study of the information needs of high‐risk women undergoing prophylactic oophorectomy , 2000, Psycho-oncology.

[50]  T. Sellers,et al.  Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. , 2000, JAMA.

[51]  R. Croyle,et al.  Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. , 2000, Preventive medicine.

[52]  P. Butow,et al.  Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  P. Devilee,et al.  Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation , 2000, The Lancet.

[54]  K. Sandelin,et al.  Initial experiences of women from hereditary breast cancer families after bilateral prophylactic mastectomy: a retrospective study. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[55]  T. Rebbeck,et al.  Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  P. Borgen,et al.  Women’s Regrets After Bilateral Prophylactic Mastectomy , 2000, Annals of Surgical Oncology.

[57]  Suzanne M. Miller,et al.  Decision making about prophylactic oophorectomy among at-risk women: psychological influences and implications. , 1999, Gynecologic oncology.

[58]  C K Redmond,et al.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.

[59]  P. Butow,et al.  Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer. , 1999, Gynecologic oncology.

[60]  O. Olopade,et al.  Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. , 1999, Journal of the National Cancer Institute.

[61]  P. Borgen,et al.  Issues of Regret in Women With Contralateral Prophylactic Mastectomies , 1999, Annals of Surgical Oncology.

[62]  J. Benkendorf,et al.  Bilateral prophylactic mastectomy decision making: A vignette study. , 1999, Preventive medicine.

[63]  P. Stalmeier,et al.  Evaluation of a Shared Decision Making Program for Women Suspected to Have a Genetic Predisposition to Breast Cancer , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.

[64]  P. Stalmeier,et al.  Assessment of the Time-tradeoff Val ues for Prophylactic Mastectomy of Women with a Suspected Genetic Predisposition to Breast Cancer , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[65]  M. Shepard Tamoxifen and Breast Cancer Prevention , 1998 .

[66]  P. Boyle,et al.  Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women , 1998, The Lancet.

[67]  M. Piver,et al.  Extraovarian primary peritoneal carcinoma. , 1998, Oncology.

[68]  N. Hallowell ‘You don’t want to lose your ovaries because you think ‘I might become a man' ’. Women's perceptions of prophylactic surgery as a cancer risk management option , 1998, Psycho-oncology.

[69]  J Chang-Claude,et al.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.

[70]  L. Temple,et al.  Is incidental prophylactic oophorectomy an acceptable means to reduce the incidence of ovarian cancer? , 1997, American journal of surgery.

[71]  K M Kuntz,et al.  Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. , 1997, The New England journal of medicine.

[72]  B. Littenberg,et al.  The effect of an educational intervention on the perceived risk of breast cancer , 1996, Journal of General Internal Medicine.

[73]  K. Helzlsouer,et al.  Predictors of and satisfaction with bilateral prophylactic mastectomy. , 1995, Preventive medicine.

[74]  A. Kurjak,et al.  Ovarian cancer screening , 1994, Current opinion in obstetrics & gynecology.

[75]  M. Piver,et al.  Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the gilda radner familial ovarian cancer registry , 1993, Cancer.

[76]  K. Lu,et al.  Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation , 2005 .

[77]  S. Narod,et al.  Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer , 2004, Familial Cancer.

[78]  I. Jacobs,et al.  Ovarian cancer screening , 2002, Hospital medicine.

[79]  Anne,et al.  BREAST CANCER AFTER PROPHYLACTIC BILATERAL MASTECTOMY IN WOMEN WITH A BRCA 1 OR BRCA 2 MUTATION , 2001 .

[80]  L. Fallowfield,et al.  questionnaires and semistructured interviews mastectomy : prospective study using The psychosocial impact of bilateral prophylactic , 2001 .

[81]  E. Swisher,et al.  Prophylactic oophorectomy and ovarian cancer surveillance , 2001 .

[82]  P. Oefner,et al.  Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group. , 2000, British journal of cancer.

[83]  D. Easton,et al.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.